Boehringer Ingelheim Investigational Site

Fayetteville, North Carolina

0 studies enrolling now · 1 studies all time

What they study most

Lymphoma, Non-Hodgkin

Studies at this site

• BI 695500 vs Rituxan First Line Treatment in Patients With Low Tumor Burden Follicular Lymphoma — Stopped early